Exterro Upgrades Fusion With Data Map

NEW YORK -- At LegalTech New York, Exterro, the legal industry’s most trusted provider of software solutions for the legal industry, today unveiled Fusion Genome. Exterro’s Fusion Genome is the first dynamic data mapping solution that allows corporate legal and IT teams to identify, manage and analyze the lifecycle of data sources and information comprehensively across an enterprise, and keep that information evergreen. Built atop Exterro’s proven Fusion workflow platform, Genome gives companies the automated, matter-specific data map they need to understand their rapidly evolving information universe. Now, corporations can have an end-to-end risk assessment and management solution built on one workflow platform. To view a demonstration of the solution, stop by booth No. 1711 at LegalTech® New York.

Complex and far-reaching regulations, such as the Federal Rules of Civil Procedure (FRCP), have left corporate legal teams and IT departments exposed to increased scrutiny. Failure to understand and manage an enterprise’s data landscape puts it at high risk for incurring significant expenses when responding to regulatory or e-discovery requests. The ad-hoc and manual management systems largely in place today are inadequate to meet the increasing demands and responsibility for information. Legal, IT and records management teams have been looking for a solution that delivers a company-wide, dynamic data map capable of evolving with an enterprise’s information inventory. Genome delivers this solution and integrates seamlessly, through the Fusion platform, to their legal hold and e-discovery tools.

“Our Fortune 500 clients’ biggest pain points lie in keeping their data maps current. They often rely on error-prone tribal knowledge to manage a great number of data sources and systems, resulting in difficulty when implementing regulatory and compliance policies,” said Bobby Balachandran, CEO of Exterro, Inc. “Even consulting companies have expressed a need for an evergreen information management tool. Exterro has worked extensively with its client base to develop Fusion Genome. One large client anticipates a three-year ROI of over 500%.”

Exterro Inc.